INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Other acquisition or disposition
J—
68.1K sh
Dec 8, 2025Dec 10, 2025
Page 1677 of 1855
← PrevNext →
traded Dec 8, 2025
+2d
SEC Form 4

Evidence

12
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Gift
G—
1,660 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

11
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$625K
4,153 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$40K
4,004 sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
200 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
200 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$493K
3,296 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
400 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

11
BS
Baig SaqibChief Accounting Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$32K
5,000 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

10
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M$335K
1,289 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

10
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$179K
16.2K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Tax withholding
F$38K
168 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
43.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
42.5K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
MB
MacDonald Neil BEVP, GM, Server
HPEHewlett Packard Enterprise Co
Option exercise
M—
47.7K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HH
Hancock Lynn HSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
3 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
7,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
88.3K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
SG
Schjotz GitteSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
9 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
10.0K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
SS
Seyedkazemi SetarehCHIEF DEVELOPMENT OFFICER
ADVMAdverum Biotechnologies, Inc.
Tender of shares
U—
54.9K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
PM
Patel Ketan MPresident, Personal Systems
HPQHP INC
Grant or award
A—
77.5K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
CA
Chakravarthy ArthiChief Legal Officer
ENVXEnovix Corp
Tax withholding
F$8,107
934 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
CS
Chapin Linda SEVP & CHRO
ULSUL Solutions Inc.
Grant or award
A—
4 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HC
Hilberg ChristopherChief Risk & Compl. Officer
SKYTSkyWater Technology, Inc
Tax withholding
F$16K
867 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
OG
Ozden Rabia GursesChief Medical Officer
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
85.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
MB
MacDonald Neil BEVP, GM, Server
HPEHewlett Packard Enterprise Co
Grant or award
A—
146.7K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
GA
Genovesi John ASee Remarks
ULSUL Solutions Inc.
Grant or award
A—
6 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
HH
Hancock Lynn HSee Remarks
ULSUL Solutions Inc.
Grant or award
A—
5 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
PD
Porteous William D.Director
BKSYBlackSky Technology Inc.
Grant or award
A—
1,500 sh
Dec 10, 2025Dec 10, 2025
traded Dec 10, 2025
+0dSEC Form 4

Evidence

9
GF
Goins Melanie FGeneral Counsel and CPO
DIBS1stdibs.com, Inc.
Option exercise
M—
8,990 sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
1,250 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
DL
Dillow Stacy LEVP, Chief People Officer
HPEHewlett Packard Enterprise Co
Grant or award
A—
77.5K sh
Dec 8, 2025Dec 10, 2025
traded Dec 8, 2025
+2dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
HS
Hong SooDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence

9
LL
Lupher, Jr. Mark L.Director
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
3,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC Form 4

Evidence